These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10803607)

  • 1. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays.
    Parker GJ; Law TL; Lenoch FJ; Bolger RE
    J Biomol Screen; 2000 Apr; 5(2):77-88. PubMed ID: 10803607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a high-affinity anti-phosphoserine antibody for the development of a homogeneous fluorescence polarization assay of protein kinase C.
    Wu JJ; Yarwood DR; Pham Q; Sills MA
    J Biomol Screen; 2000 Feb; 5(1):23-30. PubMed ID: 10841597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence polarization competition immunoassay for tyrosine kinases.
    Seethala R
    Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence polarization competition immunoassay for tyrosine kinases.
    Seethala R; Menzel R
    Anal Biochem; 1998 Jan; 255(2):257-62. PubMed ID: 9451512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
    Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
    Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening assays for estrogen receptor by using coumestrol, a natural fluorescence compound.
    Wang C; Li C; Zhou H; Huang J
    J Biomol Screen; 2014 Feb; 19(2):253-8. PubMed ID: 24019253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of synthetic estrogens with human estrogen receptors.
    Nikov GN; Eshete M; Rajnarayanan RV; Alworth WL
    J Endocrinol; 2001 Jul; 170(1):137-45. PubMed ID: 11431146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An affinity-based fluorescence polarization assay for protein tyrosine phosphatases.
    Zhang S; Chen L; Kumar S; Wu L; Lawrence DS; Zhang ZY
    Methods; 2007 Jul; 42(3):261-7. PubMed ID: 17532513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence polarization is a useful technology for reagent reduction in assay miniaturization.
    Kowski TJ; Wu JJ
    Comb Chem High Throughput Screen; 2000 Oct; 3(5):437-44. PubMed ID: 11032959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
    Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
    Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
    Harris A; Cox S; Burns D; Norey C
    J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput fluorescence polarization method for identifying ligands of LOX-1.
    Zhang TT; Huang ZT; Dai Y; Chen XP; Zhu P; Du GH
    Acta Pharmacol Sin; 2006 Apr; 27(4):447-52. PubMed ID: 16539845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homogeneous assay of kinase activity that detects phosphopeptide using fluorescence polarization and zinc.
    Scott JE; Carpenter JW
    Anal Biochem; 2003 May; 316(1):82-91. PubMed ID: 12694730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
    Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor binding assay method for endocrine disruptors using fluorescence polarization.
    Ohno K; Fukushima T; Santa T; Waizumi N; Tokuyama H; Maeda M; Imai K
    Anal Chem; 2002 Sep; 74(17):4391-6. PubMed ID: 12236347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unusual binding properties of the third distinct teleost estrogen receptor subtype ERbetaa are accompanied by highly conserved amino acid changes in the ligand binding domain.
    Hawkins MB; Thomas P
    Endocrinology; 2004 Jun; 145(6):2968-77. PubMed ID: 15001543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases.
    Loomans EE; van Doornmalen AM; Wat JW; Zaman GJ
    Assay Drug Dev Technol; 2003 Jun; 1(3):445-53. PubMed ID: 15090181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.